Business Wire

$650 Million Private Equity Group ‘PIR Equities’ Is Investing $50M In Blockchain

Del

PIR Equities, an employee owned private equity firm focused on opportunistic value-based investing, is optimistic about the future of blockchain technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180830005717/en/

Private equity group ‘PIR Equities’ investing in blockchain. (Graphic: Business Wire)

Private equity group ‘PIR Equities’ investing in blockchain. (Graphic: Business Wire)

Established in 2008 by Joseph Aaron Horowitz and Oded ‘O.D.' Kobo, the firm manages a varied portfolio including interests in property, securities, technology and ownership in operating businesses with over $650 million in assets.

PIR Equities has committed to invest $50 million in blockchain technology companies over the next 12 months. The company plans to support blockchain entrepreneurs and the community, which was founded on ideals of openness and decentralization. In a recent report by Managing Partner Joseph Aaron Horowitz to employees, he writes, “We have entered the digital economy and blockchain is as significant today as the Internet was 25 years ago. There are many uses for this emerging technology and the more we are involved, the more we can try to leverage it, and as a long-term investment firm we must be there."

In an interview with South China Morning Post, PIR Equities Co-founder, O.D. Kobo, stated, “I have long been an advocate of blockchain technology as well as personally investing in various digital currencies since 2016, including Bitcoin and Ethereum. I am happy that I have finally managed to convince the rest of my partners and the investment committee at PIR Equities to enter the space.”

Joseph Aaron Horowitz is the Managing Partner at PIR Equities and serves as a member of the investment committee. Prior to joining PIR Equities in 2008, Mr. Horowitz held various executive roles at Goldman Sachs and was a member of the Financial Institutions Group at Morgan Stanley as a senior analyst.

Oded ‘O.D.’ Kobo is an accomplished Internet entrepreneur and businessman with over $250 million in technology related exists over the last decade. Mr. Kobo is a co-founder of PIR Equities, and has assisted in raising nearly $1.1 billion in capital for various startups, real estate investment groups and private equity funds. An avid start-up investor and mentor, Mr. Kobo sits on the board of over 30+ companies.

Contact information

PIR Equities
Julianne Haub
info@PIRequities.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Scientist.com Hosts Webinar Exploring Global Strategies for Sourcing of Real World Evidence (RWE) and Health Economics and Outcomes Research (HEOR)16.1.2019 12:55Pressemelding

Scientist.com, the life science industry’s leading online marketplace for outsourced research services, announced today that it has assembled a panel of industry experts to discuss best practices and global strategies when sourcing HEOR and RWE services. Set for January 24, 2019, at 12:00pm EDT, the webinar will focus on how the industry currently defines RWE and HEOR, some of the major challenges research organizations face when sourcing RWE and HEOR and emerging global trends in the strategy and regulation of RWE (including HEOR, epidemiology, market access and other RWE). “I am excited to serve on such a distinguished panel focusing on the practical uses of real world data,” said Patti Peeples, RPh, PhD, CEO and Founder, HealthEconomics.com, and Principal Researcher, HE Institute. “Many research organizations are looking to maximize this data to optimize market access while informing value-focused healthcare decisions and reducing research costs.” The panel consists of experts in RW

Bank of America Reports Fourth-Quarter 2018 Financial Results16.1.2019 11:45Pressemelding

Bank of America reported its fourth-quarter 2018 financial results today. The news release, supplemental filing and investor presentation can be accessed in the following ways: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190116005355/en/ Bank of America newsroom at https://newsroom.bankofamerica.com Bank of America Investor Relations website at http://investor.bankofamerica.com Business Wire’s news webpage at http://www.businesswire.com/portal/site/home/news Investor Conference Call information Chief Executive Officer Brian Moynihan and Chief Financial Officer Paul Donofrio will discuss the financial results in a conference call at 8 a.m. ET today. For a listen-only connection to the conference call, dial 1.877.200.4456 (U.S.) or 1.785.424.1732 (international). The conference ID is 79795. Please dial in 10 minutes prior to the start of the call. Investors can also listen to a live audio webcast of the conference call and

Knopp Biosciences Expands Research Collaboration with Cincinnati Children’s to Characterize Effect of Dexpramipexole in Inflammatory Diseases16.1.2019 11:00Pressemelding

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with a high unmet need, today announced the expansion of its research collaboration with Cincinnati Children’s Hospital Medical Center to further elucidate the eosinophil-depleting mechanism of action of Knopp’s lead investigational drug, dexpramipexole. Eosinophils are white-blood cells that play a central role in several debilitating conditions, including asthma, hypereosinophilic syndrome (HES), and other inflammatory diseases. Dexpramipexole has been shown to selectively reduce eosinophil levels in multiple clinical trials, including a Phase 2 study in HES and a Phase 2 trial in chronic rhinosinusitis with nasal polyps. Knopp is advancing dexpramipexole into Phase 2 development in severe asthma and Phase 3 development in HES. The research at Cincinnati Children’s Hospital Medical Center is being led by Patricia C. Fu

Eurosport Signs an Exclusive Multi-Year Partnership Deal with Outbrain, Which Includes Outbrain’s Smartfeed and Video Technology16.1.2019 11:00Pressemelding

Outbrain, the world’s leading native advertising platform, announced today it has signed a pan-regional deal with Eurosport, the number one destination for sports fans. The agreement spans 13 markets globally, including the UK, France, Germany, Italy, Spain, Asia, and Australia, and will be powered by Outbrain’s innovative Smartfeed technology. Smartfeed provides a content discovery feed that allows publishers to customise the user experience, improving both engagement and revenue. It is designed for a range of content from promoted articles to editorial pieces to videos, and functions across all devices including desktop, mobile, and apps. Eurosport will also utilise Outbrain’s Amplify platform to promote their own videos. Earlier this year, Outbrain released Focus, a click-to-watch video experience built for engagement and performance, and tailored for high quality and long form video content. Focus consistently results in higher click-through and completion rates, which makes it ide

NexPlayer Supporting Low Latency HLS & DASH Streaming on Android, iOS, Smart TVs, STBs, PCs, and Macs16.1.2019 09:52Pressemelding

As part of their mission to provide the most advanced feature set, NexPlayer has added low latency functionality to its media players. NexPlayer allows you to enable low latency streaming with HLS and DASH on all devices, solving the latency problem and improving the OTT viewing experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190116005301/en/ Latency is a serious issue for streaming services, as live playback with HLS and DASH typically falls 30 seconds to a minute behind the live event. With linear TV only 6 seconds behind, OTT viewers find out what happens via social media or text before seeing it firsthand. Now with the support of NexPlayer, media organizations can achieve sub-6 second latency on Android, iOS, Smart TVs, STBs, PCs, and Macs. In the past, the only ways to achieve low latency were through proprietary end-to-end protocols or by foregoing ABR support. Both methods have considerable drawbacks. Propr

Temenos Revolutionises its Banking Software, with the Launch of Two New Cloud-Native, Cloud-Agnostic Products – Temenos Infinity & Temenos T24 Transact to Accelerate Cloud Adoption16.1.2019 08:43Pressemelding

Temenos (SIX: TEMN) the banking software company, today marked a major milestone with the launch of two new products. Temenos Infinity – a breakthrough digital front office product and Temenos T24 Transact – the next generation in core banking. These new products combine the most complete banking functionality in the market, leveraging 25 years of functionality from 3,000 banks in over 150 countries with the most advanced cloud-native, cloud-agnostic, API first technology and design-led thinking. Through APIs, both products can be implemented independently or integrated. Clients will be able to roll-out new applications in hours utilising advanced continuous deployment tools and methodologies. The conversion from Temenos’ existing Digital Front Office and T24 Core Banking products are automatic and upgrades for existing clients to the new cloud-native, cloud-agnostic Temenos products are available from April 2019. All Temenos SaaS products run on the new Temenos platform. Temenos Infin